SLC6A4 and depressive disorder: The levels of serotonin in the synaptic cleft are regulated by the serotonin reuptake transporter (SERT), and to restore serotonin levels in depressive subjects, drugs targeting SERT, known as selective serotonin-reuptake inhibitors (SSRI), are considered the first-line treatment for depressive disorders [4,5].